Brian K. Campion, Ph.D..

Brian K. Campion, Ph.D.

Brian joined Regulus in July 2020 as Vice President, Business Development. His career includes corporate business development roles at Dermira Inc. (Eli Lilly), Bird Rock Bio and Ora Inc. While at Dermira he led technology in-licensing activities to expand Dermira’s product and technology portfolio. He was instrumental in securing a multi-target in-licensing partnership with Takeda Pharmaceuticals and the transformative in-licensing of global rights for Lebrikizumab from Roche. Dermira was acquired by Eli Lilly in January of 2020. Brian received his B.A. and Ph.D. degrees in chemistry from the University of California, San Diego and was a postdoctoral Fellow at UC Berkeley.